stimuli generate driving forces from the interaction between the micro/nanorobots and aspects of the treatment microenvironment, such as pH, enzymes, and redox potential. [4][5][6][7][8][9] However, the controllability of endogenous power-driven cell robots is limited, considering tumor heterogeneity. In addition, the cell robots may lose driving force when local lesions are cured. In contrast, driving forces generated from externally-applied fields are controllable, and can be output continuously. Micro/ nanorobots for biomedical applications, driven by optical, [9][10][11][12][13] acoustic, [14][15][16][17][18] or magnetic fields, [19][20][21][22][23] have been reported. In particular, micro/nanorobots controlled by magnetic fields have been studied extensively, because magnetic fields can penetrate tissues without attenuation of energy. [23][24][25][26] In general, magneticallycontrolled micro/nanorobot systems can be divided into two components: the magnetic manipulation platform (MMP), and the magnetized micro/nanorobot (MMR). The MMP relies primarily on the characteristics of superimposed magnetic fields, generated by different coils, that can be oriented in any desired direction. [27,28] To be biocompatible, cell membranes, [29] cell derived vesicles, [30] or natural cells [31,32] can be used to camouflage MMRs. [33] Magnetized cell-based robots (MCRs) are particularly effective in targeted treatment of tumors, owing to their homology with the patient, which not only gives the cell carrier excellent biocompatibility, but also takes advantage of the cells' specialized functions. [34,35] MCR fabrication is typically manifested as adhesion of magnetic materials to the cell membrane, or entry of magnetic materials to the cell by means, such as electrostatic adsorption or endocytosis. Examples of the latter strategy include the loading of red blood cells, [36][37][38] macrophages, [32,39] and stem cells [40,41] with iron oxide nanoparticles (NPs) containing drugs, for effective targeting of lesion locations under magnetic drive. However, with this strategy, drug loading is limited, to avoid influencing the activity of cells. An alternative strategy is to wrap the drugs in a membrane, and release them when the cell robots reach the lesion location. For example, liposome or polymer NPs can be loaded into live macrophages thanks to their natural phagocytic function, and the load-drugs can subsequently be released under endogenous or exogenous Injecting micro/nanorobots into the body to kill tumors is one of the ultimate ambitions for medical nanotechnology. However, injecting current micro/ nanorobots based on 3D-printed biocompatible materials directly into blood vessels for targeted therapy is often difficult, and mistakes in targeting can cause serious side effects, such as blood clots, oxidative stress, or inflammation. The natural affinity of macrophages to tumors, and their natural phagocytosis and ability to invade tumors, make them outstanding drug delivery vehicles for targeted tumor therapy. Hence, a mag...